Please login to the form below

Not currently logged in

Spectrum Pharmaceuticals supports Fusilev with digital marketing campaign

Campaign for cancer drug includes a new website, HCP education tools and resources, and live programmes

US-based Spectrum Pharmaceuticals has launched a digital marketing campaign for its colorectal cancer drug Fusilev (levoleucovorin).

Featuring a new website, healthcare professional (HCP)educational tools, and live peer-to-peer educational programmes, the campaign will be aimed at oncologists, nurses, office practice managers and pharmacists.

"Strong commercial support for Fusilev has been rewarded by increased market penetration and sustained customer loyalty," said Rajesh Shrotriya, chairman, chief executive officer, and president of Spectrum Pharmaceuticals.

“We believe this campaign will continue to raise awareness of the Fusilev brand as well as grow the folate analog market."

20th August 2012


Featured jobs

Subscribe to our email news alerts


Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

A marathon and a sprint
Customer experience is a long-distance race and with pharma late out of the blocks, companies need to put their foot down if they want to compete...
5 tactics to master Market Access
Is it time to rethink your game plan? To succeed at Market Access, follow these 5 tactics:...
Finding the patient voice
How patients feel and speak about clinical trials...